Print this page    •   Back to Web version of article

International News
AIDS Activists Commend, Criticize Uganda's Option B+ Implementation

November 27, 2013

"Uganda has gotten plenty of kudos and some criticism over its roll out of the new antiretroviral therapy for pregnant women and their babies, known as Option B+," Inter Press Service reports. "Recommended by the [WHO] in June 2012, Option B+ consists in life-long provision of [antiretroviral (ARV)] therapy to pregnant women regardless of their CD4 count," the news service writes and summarizes comments from AIDS activists, who "welcomed the roll out but voiced some concerns." According to IPS, the International Community of Women Living with HIV/AIDS in Eastern Africa (ICWEA) said in a statement, "We strongly support Option B+ ... But we are gravely concerned ... about two major early challenges, loss to follow-up and weak engagement of communities, which will lead to weak demand for this service" (Michael, 11/27).

Back to other news for November 2013


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.




This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/73329/aids-activists-commend-criticize-ugandas-option-b-.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.